Massachusetts Clinic Offers Ketamine IV Therapy To Reduce Antidepressant Dependence

Toda antid ever rates say, work

ThriveIVoffersFDA-approved ketamineIVtherapywithaproven trackrecordforreducing depressionsymptomslong-term, evenforthosewithtreatmentresistantdepression.

Recentstudiesshowonedose ofketaminetoprovidea significantimprovementin depression-relatedsymptoms, whichcontinuedonemonth afterthetreatment.

Manyantidepressantscan causeinsomnia,headaches, digestiveproblems, decreasedsexualdriveor impotency,andcanincrease patients'riskofinternal bleeding.

Unfortunately,theefficacyof thesemedicationsisoften poororerratic,beingeffective forthefirstfewmonthsbut thencausingdepression symptomstoactuallyworsen.

ThriveIV'sketamineIV therapyusuallyconsists ofsixsessionstaking placeovera2-to3-week period.